Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients

Clinical trial NCT06381947 · UNKNOWN

Trial details

NCT number: NCT06381947
Sponsor: University of Salerno
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Dyslipidemias Statin Adverse Reaction Cardiovascular Diseases Lipid Metabolism Disorders

Start date: 2024-05-01
Primary completion: 2025-06-30
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.